(R)-tert-Butyl 3-hydroxypent-4-enoate

Catalog No. :
ACLUBS390
CAS No. :
220861-37-0
Molecular Formula :
C9H16O3
Molecular Weight :
172.22

IUPAC Name:tert-butyl (R)-3-hydroxypent-4-enoate

(R)-tert-Butyl 3-hydroxypent-4-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$147.00Login to see priceIn stockInquiry
100mg97%$230.00Login to see priceIn stockInquiry
250mg97%$276.00Login to see priceIn stockInquiry
1g97%$689.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 3-hydroxypent-4-enoate
IUPAC Nametert-butyl (R)-3-hydroxypent-4-enoate
MDL No.MFCD18207181
Molecular FormulaC9H16O3
Molecular Weight172.22
SMILESC=C[C@@H](CC(OC(C)(C)C)=O)O
InChI KeyOBFPCKWYDQCBHO-ZETCQYMHSA-N
Synonym(R)-tert-butyl 3-hydroxypent-4-enoate;Vaborbactam Related Compound 2;4-Pentenoic acid, 3-hydroxy-, 1,1-dimethylethyl ester, (3R)-;Vaborbactam Impurity 2;tert-butyl (3R)-3-hydroxypent-4-enoate;tert-butyl (R)-3-hydroxypent-4-enoate;1,1-Dimethylethyl (3R)-3-hydroxy-4-pentenoate
CAS No.220861-37-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLUBS390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUBS390 route product structure diagram
    ACLUBS390220861-37-0 In Stock
Inquiry

2. ACLUBS390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLUBS390 route product structure diagram
    ACLUBS390220861-37-0 In Stock
Inquiry

Comments (0)